Please login to the form below

Not currently logged in
Email:
Password:

Former NICE chair Sir Michael Rawlins to lead MHRA

He will take up his new role at the UK's medicines and devices regulator in December

sir-michael-rawlins-mhraThe UK's Medicines and Healthcare Products Regulatory Agency (MHRA) has named UK healthcare veteran Sir Michael Rawlins as its new chair.

Sir Michael will take up his new post on December 1, 2014 and replace Sir Gordon Duff, who earlier this year announced his intention to step down from the regulator to focus on his academic career.

Sir Gordon has been in the position for just under two years during which time he has overseen a period of major change for the agency, which is responsible for protecting and improving the health of people in the UK

The task will now fall to Sir Michael, who is no stranger to senior positions in UK healthcare having spent 14 years as chairman of the National Institute for Health and Care Excellence (NICE) from its formation in 1999 to his departure last year.

He is also an honorary professor at the London School of Hygiene and Tropical Medicine, University of London, and emeritus professor at the University of Newcastle upon Tyne.

More recently Sir Michael has served on the board of US-based biotech Intra-Cellular Therapeutics.

The appointment was welcomed by England's chief medical officer Prof Dame Sally Davies.

“I am delighted at Sir Michael Rawlins' appointment as agency chair,” she said. “He will bring a wealth of experience to the Board and will play a key role in the leadership of our national regulator who will continue to focus on excellence and innovation.”

4th November 2014

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics